RPA1 and nasopharyngeal carcinoma: Radiotherapy is the primary and curative treatment for NPC.[23] Our data confirm that RPA1 plays a role in modulating the radiosensitivity of NPC cells, whereby overexpression of RPA1 leads to radioresistance.